Target intelligence / Profile preview

Aspartate-semialdehyde dehydrogenase (ASADH)

Target
ASADH
Molecular classification
Enzyme, Oxidoreductase (EC 1.2.1.11), Sometimes classified as "metabolic enzyme" or "catalyst of aspartate pathway", Not a receptor, transporter, or ion channel
01

Overview

Aspartate-semialdehyde dehydrogenase (ASADH) is an essential oxidoreductase enzyme (EC 1.2.1.11) found in bacteria, fungi, and some plants, but absent in mammals. It catalyzes a key step in the aspartate pathway, converting β-aspartyl phosphate to L-aspartate-β-semialdehyde, a precursor for the biosynthesis of amino acids such as lysine, methionine, threonine, isoleucine, and leucine, as well as intermediates necessary for bacterial cell wall formation (e.g., diaminopimelate). ASADH is structurally well-characterized as a dimer or tetramer (depending on species), uses NADP+ as a cofactor, and contains a critical cysteine residue in its active site. Because its disruption is lethal to microorganisms, ASADH is a promising target for antibacterial, antifungal, and herbicidal drug development. Inhibitors under investigation typically act by blocking substrate or cofactor binding or through covalent modification of the active site. The enzyme is absent in humans, allowing for highly specific targeting of pathogens with minimal expected off-target toxicity[1][2][3][4][5][6][7][8][9].

Other names
Aspartate semialdehyde dehydrogenaseAspartic semialdehyde dehydrogenaseL-aspartate-beta-semialdehyde:NADP+ oxidoreductase (phosphorylating)Aspartic beta-semialdehyde dehydrogenaseASA dehydrogenase
02

Mechanism of action

Competitive inhibition of substrate or NADP+ binding to active site. Covalent inhibition at the essential cysteine in active site. Enzyme inactivation leads to interruption of amino acid biosynthesis, causing cell death or growth arrest in target organisms.

03

Biological functions

Amino acid biosynthesis (lysine, methionine, threonine, isoleucine, leucine)Metabolite biosynthesis (e.g. diaminopimelate for cell wall)Aspartate pathway catalysis: specifically, reductive dephosphorylation of β-aspartyl phosphate to L-aspartate-β-semialdehydeCell wall synthesis in bacteria (indirectly via diaminopimelate)
04

Disease associations

Infection (essential for viability of many bacteria, including antibiotic-resistant pathogens like Pseudomonas aeruginosa and Neisseria gonorrhoeae, as well as fungi and some parasites)Plant and fungal pathogens (potentially herbicide and antifungal target)Does not play a disease role in humans, but is a key anti-infective target due to bacterial and fungal essentiality
05

Safety considerations

Specificity: ASADH is not present in humans/mammals, so off-target toxicity should be low; however, extensive safety profiling is still necessary for drug developmentResistance risk: As with other antibacterial targets, potential for resistance development existsNo direct safety issues reported in current scientific literature
06

Interacting drugs

No clinically approved drugs directly listed yet

2 more in the full profile.

07

Biomarkers

No common diagnostic biomarkers for this enzyme in human disease contextMay be targetable for species-specific detection in research or development settingsUpregulation documented in certain fungal infections (e.g., Trichophyton rubrum exposed to human skin)

Beyond the preview

Go deeper on Aspartate-semialdehyde dehydrogenase (ASADH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aspartate-semialdehyde dehydrogenase (ASADH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call